TipRanks
Claritev (CTEV)
NYSE:CTEV
US Market
Want to see CTEV full AI Analyst Report?
EarningsQ2 2026 Earnings Report

Claritev (CTEV) Q2 2026 Earnings Report

277 Followers

CTEV Q2 2026 EPS Results

Actual EPS-$3.49
Consensus EPS-$4.12
Beat/MissBeat by +$0.63
One Year Ago EPS-$3.81

CTEV Q2 2026 Revenue Results

Actual Revenue$257.48M
Expected Revenue$244.81M
Beat/MissBeat by +$12.67M
YoY Revenue Growth+6.59%

Earnings Announcement Details

QuarterQ2 2026
Date08/07/2026
TimeBefore Open
Conference CallFriday, August 7, 2026
CTEV Upcoming Earnings
Claritev's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CTEV Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: multi-quarter revenue growth, record/near-record EBITDA and cash flow, significant bookings acceleration and a substantially enlarged pipeline. Management raised revenue and EBITDA guidance and highlighted successful execution across TPA, Claims Intelligence and AI-enabled initiatives. Offsetting considerations include timing and mix-driven pressure on revenue per claim, network comparables impacted by prior-year one-time items, a near-term Payments timing miss, and some volume/regulatory uncertainty that introduces short-term variability. Overall, the positive metrics and trajectory substantially outweigh the manageable timing and mix headwinds.
Company Guidance
Claritev raised its full‑year revenue guidance to $1.00–$1.02 billion (4%–6% growth, a two‑percentage‑point increase) and asked investors to model Q3 revenue flat with Q2, raised full‑year adjusted EBITDA guidance to $610–$620 million (≈61% margin), left capital spending unchanged at $160–$170 million, and increased free cash flow guidance by $5 million to $5–$15 million; management expects adjusted cash conversion to normalize to >50% by year‑end, reiterated that new ACV bookings typically convert to first revenue in ~2–4 quarters and fully annualize after another ~4 quarters, reaffirmed a target of at least 50% ACV bookings growth for 2026 (Q2 ACV was $30M, H1 ACV ~$74M with a $100M full‑year stretch goal), highlighted a >$300M active pipeline with >3x coverage, and reminded listeners of the near‑term cash seasonality (Q1 and Q3 generally consume cash; Q2–Q4 generate cash).
Revenue Growth and Record Quarter
Total revenue $257.5M in Q2, up 6.6% year-over-year — fifth straight quarter of YoY growth and the highest revenue quarter in 15 quarters (since Q3 2022).
Strong Adjusted EBITDA and Margins
Q2 adjusted EBITDA $155.8M, representing 60.5% of revenue — strongest absolute EBITDA in 13 quarters and margins in line with expectations.
Robust Cash Flow Performance
Operating cash flow $93M (up 51% YoY); unlevered free cash flow $89.5M (up 24% YoY); levered free cash flow $54.6M (up 49% YoY) — highest levered FCF in 15 quarters. Working capital metrics (DPO/DSO) improved by >5 days.
Bookings Momentum and Pipeline Expansion
Q2 ACV bookings $30M and first-half ACV bookings $74M (up 150% year-to-date vs prior year). Active pipeline >$300M (up 50% comparable) with >3x coverage; management expects to exceed $100M bookings for the year.
Deal Size and Sales Execution Improvements
Average deal size increased by more than 300% on an absolute dollar basis through H1; closed 16 deals >$1M ACV (up 25% vs prior year). Cross-sell/upsell accounted for ~75% of bookings.
Segment Performance — Claims Intelligence & PSAV
Claims Intelligence grew ~14% in Q2. Total PSAV revenue $220M — highest level in nearly 4 years. Q2 total PSAV dollars grew 8% sequentially and 10% YoY.
Raised Full-Year Financial Guidance
Revenue guidance raised to $1.00B–$1.02B (4%–6% growth) and full-year adjusted EBITDA guide raised to $610M–$620M (~61% margin). Free cash flow guide increased by $5M to $5M–$15M. Capex guidance unchanged at $160M–$170M.
TPA and New Vertical Momentum
TPA vertical was the largest contributor to Q2 bookings (several 7-figure deals) and expected to contribute roughly 30% of total new bookings this year. Early wins in Medicare Advantage and public sector expanding addressable market.
Technology Modernization and AI Progress
Ongoing digital transformation (cloud migration, data architecture modernization) enabling AI deployment. CEO/CFO cited dozens of AI models/use cases in production; ProPricer AI initiative identified over $1B of additional savings. IDR arbitration outcomes outperform industry by ~8 percentage points.
Third-Party Recognition and Notable Wins
Everest Group recognized Claritev as a leader in payment integrity. Notable client wins include Marpai and multiple large NSA and PRI engagements supporting momentum.

CTEV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 10, 2026
2026 (Q3)
-3.63 / -
-4.23―
2026 (Q2)
-4.12 / -3.49
-3.818.40% (+0.32)
2026 (Q1)
-4.09 / -4.41
-4.38-0.68% (-0.03)
2025 (Q4)
-2.79 / -4.88
-8.8244.67% (+3.94)
2025 (Q3)
-3.59 / -4.23
-24.2582.56% (+20.02)
Aug 06, 2025
2025 (Q2)
-1.45 / -3.81
-35.689.30% (+31.79)
2025 (Q1)
-3.12 / -4.38
-33.286.81% (+28.82)
2024 (Q4)
-9.81 / -8.82
-1.6-451.25% (-7.22)
2024 (Q3)
-2.75 / -24.25
-1.6-1415.62% (-22.65)
2024 (Q2)
-2.22 / -35.60
-2.4-1383.33% (-33.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed